[1]
George, M., Srinivas, K. and Sriram, D.K. 2017. Empagliflozin: an exciting prospect in the treatment of diabetes. International Journal of Basic & Clinical Pharmacology. 7, 1 (Dec. 2017), 1–6. DOI:https://doi.org/10.18203/2319-2003.ijbcp20175669.